Skip to main content

Table 3 Positive bacterial culture results from sterile sites at onset and during the course of prolonged meropenem therapy

From: Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study

Intraoperative cultures (abdominal, thoracic)

blood cultures

CSF, brain tissue

Enterococcus faecium, n = 7

Enterococcus faecalis, n = 6

Stenotrophomonas maltophilia, n = 6

multidrug-resistant, carbapenem-susceptible Escherichia coli, n = 2a

Enterobacter cloacae complex, n = 2

Coagulase-negative staphylococci, n = 2

Pseudomonas aeruginosa, n = 1

Proteus mirabilis, n = 1

Proteus vulgaris, n = 1

Klebsiella pneumoniae, n = 1

Escherichia coli (non MRGN), n = 1

Staphylococcus aureus, n = 1

Enterococcus gallinarum, n = 1

E. faecalis, n = 1

E. faecium, n = 1

Vancomycin-resistant Enterococcus faecium, n = 1

E. aerogenes, n = 1

E. cloacae, n = 1

S. maltophilia, n = 1

multidrug-resistant, carbapenem-resistant P.aeruginosa, n = 1

Staphylococcus aureus, n = 1

Staphylococcus epidermidis, n = 1

Proteus mirabilis, n = 1

Bacteroides fragilis, n = 1

  1. aisolates that require unequivocally carbapenem therapy
  2. Abbreviations: n number of patients; CSF cerebrospinal fluid